Table of Contents
1 Market Overview
1.1 Nuclear Receptor ROR-Gamma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Nuclear Receptor ROR-Gamma Market
1.4.1 Global Nuclear Receptor ROR-Gamma Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 4SC AG Details
2.1.2 4SC AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 4SC AG SWOT Analysis
2.1.4 4SC AG Product and Services
2.1.5 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celgene Corporation SWOT Analysis
2.2.4 Celgene Corporation Product and Services
2.2.5 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aurigene Discovery Technologies Limited
2.3.1 Aurigene Discovery Technologies Limited Details
2.3.2 Aurigene Discovery Technologies Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aurigene Discovery Technologies Limited SWOT Analysis
2.3.4 Aurigene Discovery Technologies Limited Product and Services
2.3.5 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advinus Therapeutics Ltd.
2.4.1 Advinus Therapeutics Ltd. Details
2.4.2 Advinus Therapeutics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advinus Therapeutics Ltd. SWOT Analysis
2.4.4 Advinus Therapeutics Ltd. Product and Services
2.4.5 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb Company SWOT Analysis
2.5.4 Bristol-Myers Squibb Company Product and Services
2.5.5 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arrien Pharmaceuticals, LLC
2.6.1 Arrien Pharmaceuticals, LLC Details
2.6.2 Arrien Pharmaceuticals, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Arrien Pharmaceuticals, LLC SWOT Analysis
2.6.4 Arrien Pharmaceuticals, LLC Product and Services
2.6.5 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genfit SA
2.7.1 Genfit SA Details
2.7.2 Genfit SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genfit SA SWOT Analysis
2.7.4 Genfit SA Product and Services
2.7.5 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Brickell Biotech, Inc.
2.8.1 Brickell Biotech, Inc. Details
2.8.2 Brickell Biotech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Brickell Biotech, Inc. SWOT Analysis
2.8.4 Brickell Biotech, Inc. Product and Services
2.8.5 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biogen, Inc.
2.9.1 Biogen, Inc. Details
2.9.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biogen, Inc. SWOT Analysis
2.9.4 Biogen, Inc. Product and Services
2.9.5 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech, Inc.
2.10.1 Genentech, Inc. Details
2.10.2 Genentech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genentech, Inc. SWOT Analysis
2.10.4 Genentech, Inc. Product and Services
2.10.5 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Nuevolution AB
2.11.1 Nuevolution AB Details
2.11.2 Nuevolution AB Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Nuevolution AB SWOT Analysis
2.11.4 Nuevolution AB Product and Services
2.11.5 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teijin Pharma Limited
2.12.1 Teijin Pharma Limited Details
2.12.2 Teijin Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teijin Pharma Limited SWOT Analysis
2.12.4 Teijin Pharma Limited Product and Services
2.12.5 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline Plc
2.13.1 GlaxoSmithKline Plc Details
2.13.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline Plc SWOT Analysis
2.13.4 GlaxoSmithKline Plc Product and Services
2.13.5 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Vitae Pharmaceuticals, Inc.
2.14.1 Vitae Pharmaceuticals, Inc. Details
2.14.2 Vitae Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Vitae Pharmaceuticals, Inc. SWOT Analysis
2.14.4 Vitae Pharmaceuticals, Inc. Product and Services
2.14.5 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Phenex Pharmaceuticals AG
2.15.1 Phenex Pharmaceuticals AG Details
2.15.2 Phenex Pharmaceuticals AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Phenex Pharmaceuticals AG SWOT Analysis
2.15.4 Phenex Pharmaceuticals AG Product and Services
2.15.5 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Lead Pharma Holding B.V.
2.16.1 Lead Pharma Holding B.V. Details
2.16.2 Lead Pharma Holding B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Lead Pharma Holding B.V. SWOT Analysis
2.16.4 Lead Pharma Holding B.V. Product and Services
2.16.5 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hanmi Pharmaceuticals, Co. Ltd.
2.17.1 Hanmi Pharmaceuticals, Co. Ltd. Details
2.17.2 Hanmi Pharmaceuticals, Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
2.17.4 Hanmi Pharmaceuticals, Co. Ltd. Product and Services
2.17.5 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Visionary Pharmaceuticals, Inc.
2.18.1 Visionary Pharmaceuticals, Inc. Details
2.18.2 Visionary Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Visionary Pharmaceuticals, Inc. SWOT Analysis
2.18.4 Visionary Pharmaceuticals, Inc. Product and Services
2.18.5 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Reata Pharmaceuticals, Inc.
2.19.1 Reata Pharmaceuticals, Inc. Details
2.19.2 Reata Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Reata Pharmaceuticals, Inc. SWOT Analysis
2.19.4 Reata Pharmaceuticals, Inc. Product and Services
2.19.5 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Karo Bio AB
2.20.1 Karo Bio AB Details
2.20.2 Karo Bio AB Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Karo Bio AB SWOT Analysis
2.20.4 Karo Bio AB Product and Services
2.20.5 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.4 France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.5 India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Receptor ROR-Gamma Price by Type (2015-2020)
11 Global Nuclear Receptor ROR-Gamma Market Segment by Application
11.1 Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Receptor ROR-Gamma Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.2 Europe Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.4 South America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.3 Nuclear Receptor ROR-Gamma Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2021-2025)
12.4 Nuclear Receptor ROR-Gamma Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【免責事項】
https://www.globalresearch.jp/disclaimer